BRCA2 and breast neoplasm: The main goal of this study was to identify the principal characteristics that differentiate a family with BRCA1/BRCA2 pathogenic mutations from those with a VUS alteration and even from those BRCA1/BRCA2 WT and with sporadic breast tumors.